TESLA BOTTOMED AGAIN TODAY TED !!! HF SAYS IT'S A GO-! HOLD FOR 1 YEAR<---------------------- IRA ALERT))))))))))))))))))))))))))))))))))))TSLA WE IN THIS MORNING NOT SURE WHERE A FEW BUCKS OFF LOW!!!! gba upgrade TSLA!!!!!
GlycoMimetics, Inc. (GLYC)- DO WE LIKE OR NOT? NasdaqGM - NasdaqGM Real Time Price. 2.7950+0.1950(+7.50%) As of 02:37PM EST.
JUST SOME HOUSEKEEPING HERE. WAY BACK IN MARCH WE BOUGHT AEROJET ALL OVER IN MANY ACCOUNTS-AND I HAVE FORGOTTEN -- THESE GUYS GOT BOUGHT OUT IT'S DEAD MONEY JUST SITTING IN IRA'S-! Aerojet Rocketdyne Holdings, 39.13-0.14(-0.36%) <-- I think it's a buy here As of 12:32PM EDT. #373 Mar 21, 2022 Report Reply Share Aerojet Rocketdyne Holdings, Inc. (AJRD) NYSE - Nasdaq Real Time Price. Currency in USD 55.91-0.18(-0.32%)<----------------- RAISE CASH! As of 02:55PM EST.
TODAY- Esperion Therapeutics, Inc. (ESPR) NasdaqGM - NasdaqGM Real Time Price. 6.41+0.12(+1.83%) As of 03:07PM EST.
H.C. Wainwright bullish on Esperion as CLEAR Outcomes meets primary endpoint 12/07 ESPR H.C. Wainwright analyst Joseph Pantginis notes that Esperion has announced its Phase 3 CLEAR Outcomes trial evaluating NEXLETOL met its primary endpoint. Patients experienced a statistically significant risk reduction in MACE-4 after administration of 180 mg/day NEXLETOL compared to placebo. Pantginis expects the announcement to have a positive impact on the stock ahead of the full data, though could see increased volatility in the interim as investors weigh the news. He looks forward to the data at a major medical conference in Q1 2023. The analyst reiterates a Buy rating on the shares with a price target of $22.
WHAT DID I SAY...IT'S ANEW YEAR GET UP.. GET OUT OF THAT CHAIR... LOOK HOW FAT YOU ARE! MOVE!!! YOU NEED A WORKOUT IN THE WORST WAY....